Reactive oxygen species in acute lung injury

European Respiratory Journal

Volumn 11, Issue 3, 1998, Pages 745-757

  Chabot, F ^a   Mitchell, J A ^b   Gutteridge, J M C ^b   Evans, T W ^b  

^a CHU NANCY BRABOIS   (France)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Acute lung injury; Antioxidants; Free radicals

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ADULT RESPIRATORY DISTRESS SYNDROME; HUMAN; INFLAMMATORY INFILTRATE; LUNG INJURY; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW;

EID: 0031949161     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.11030745     Document Type: Review

References (161)

1. Bernard GR, Artigas A, Brigham KL, et al. The American-European consensus conference on ARDS. Am J Respir Crit Care Med 1994; 149: 818-824.
2. Barnes PJ, Liu SF. Regulation of pulmonary vascular tone. Pharmacol Rev 1995; 47: 87-131.
3. Zapol WM, Snider MT, Rie MA, Quinn DA, Fikker M. Pulmonary circulation during adult respiratory distress syndrome. In: Zapol WM, Falke KJ, eds. Acute respiratory failure. New York, Dekker, 1986; pp. 271-273.
4. Naeije R. Medical treatment of pulmonary hypertension in acute lung disease. Eur Respir J 1993; 6: 1521-1528.
5. Flaherty JT, Weisfeldt ML. Reperfusion injury. Free Rad Biol Med 1988; 5: 409-419.
6. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. Oxford, Oxford University Press, 1989; pp. 1-543.
7. McCord JM, Fridovich I. Superoxide dismutase: an enzymatic function for erythrocuprein (hemocuprein) J Biol Chem 1969; 24: 6045-6055.
8. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-1624.
9. Halliwell B, Cross CE, van der Vliet A, O'Neill CA, Louie S. The generation and activity of oxygen-derived species. In: Weir EK, Archer SL, Reeves JT, eds. Nitric oxide and radicals in the pulmonary vasculature. Armonk, Futura Publishing Company, 1996; pp. 21-38.
10. Fenton HJH. Oxidation of tartaric acid in presence of iron. J Chem Soc 1894; 64: 899-909.
11. Domigan NM, Charlton TS, Duncan MW, Winterbourn CC, Kettle J. Chlorination of tyrosyl residues in peptides by myloperoxidase and human neutrophils. J Biol Chem 1995; 270: 16542-16548.
12. Saran M, Bors W. Oxygen radicals acting as chemical messengers: a hypothesis. Free Rad Res Comun 1989; 7: 213-220.
13. Babior BM. Oxygen-dependent microbial killing by phagocytes. N Engl J Med 1978; 298: 659-658.
14. Sylvester JT. Oxygen radicals and the pulmonary vasculature. In: Weir EK, Archer SL, Reeves JT, eds. Nitric oxide and radicals in the pulmonary vasculature. Armonk, Futura Publishing Company, 1996; pp. 1-20.
15. Gutteridge JMC, Halliwell B. Antioxidants in nutrition, health and disease. Oxford, Oxford University Press, 1994.
16. Gutteridge JMC, Quinlan GJ. Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: the important primary role for iron-binding and iron-oxidising proteins. Biochim Biophys Acta 1993; 1156: 144-150.
17. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986; 250: H822-H827.
18. Mugge A, Elwell JH, Peterson TE, Harrison DG. Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity. Am J Physiol 1991; 260: C219-C225.
19. Oury TD, Chang LY, Marklund SL, Day BJ, Crapo JD. Immunocytochemical localization of extracellular superoxide dismutase in human lung. Lab Invest 1994; 70: 889-898.
20. Heffner JE, Repine JE. Pulmonary strategies of antioxidant defence. Am Rev Respir Dis 1989; 140: 531-554.
21. Repine JE, Parsons PK. Oxidant-antioxidant balance in endotoxin-induced oxidative injury and tolerance to oxidative injury. In: Brigham KL, ed. Endotoxin and the lung. New York, Dekker, 1994; pp. 207-217.
22. Landvik SV, Diplock AT, Packer L. Efficacy of vitamin E in human health and disease. In: Cadenas E, Packer L, eds. Handbook of Antioxidants. New York, Marcel Dekker, 1996; pp. 63-87.
23. Sies H. Oxidative stress: oxidant and antioxidants. London, Academic Press, 1991.
24. 2 tolerance. Am J Physiol 1992; 263: L22-L26.
25. White CW, Ghezzi P, McMahon S, Dinarello CA, Repine JE. Cytokines increase rat lung antioxidant enzymes during exposure to hyperoxia. J Appl Physiol 1989; 66: 1003-1007.
26. Tate RM, Vanbenthuysen KM, Shasby DM, McMurtry IF, Repine JE. Oxygen-radical-mediated permeability edema and vasoconstriction in isolated perfused rabbit lungs. Am Rev Respir Dis 1982; 126: 802-806.
27. Weiss SJ. The role of superoxide in the destruction of erythrocyte targets by human neutrophils. J Biol Chem 1980; 255: 9912-9917.
28. Traber DL, Adams T, Sziebert L, Stein M, Traber L. Potentiation of lung vascular response to endotoxin by superoxide dismutase. J Appl Physiol 1985; 58: 1005-1009.
29. Varani J, Fligiel SEG, Till GO, Kunkel RG, Ryan US, Ward PA. Pulmonary endothelial cell killing by human neutrophils: possible involvement of hydroxyl radical. Lab Invest 1985; 53: 656-663.
30. Kooy NW, Royall JA, Ye YZ, Kelly DR, Beckman JS. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med 1995; 151: 1250-1254.
31. 2 metabolites and neutrophil elastase synergistically cause edematous injury in isolated rat lungs. J Appl Physiol 1986; 61: 2224-2229.
32. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydrozynonenal, malonaldehyde and related aldehydes. Free Rad Biol Med 1991; 11: 81-128
33. Ames BN, Shigenaga MK. Oxidants are a major contributor to cancer and aging. In: Halliwell B, Aruoma OI, eds. DNA and free radicals. London, Ellis Horwood, 1993; pp. 1-15.
34. Spragg RG. DNA strand break formation following exposure of bovine pulmonary artery and aortic endothelial cells to reactive oxygen products. Am J Respir Cell Mol Biol 1991; 4: 4-10.
35. Mello Filho AC, Hoffmann ME, Meneghini R. Cell killing and DNA damage by hydrogen peroxide are mediated by intracellular iron. Biochem J 1984; 218: 273-275.
36. Clement A, Housset B. Role of free radicals in airway injury. In: Chretien J, Dusser D, eds. Environmental impact on the airways. New York, Dekker, 1996; pp. 355-379.
37. Kelley J. Cytokines of the lung. Am Rev Respir Dis 1990; 141: 765-788.
38. Mehta JL, Lawson DL, Nichols WW, Mehta P. Modulation of vascular tone by neutrophils: dependence on endothelial integrity. Am J Physiol 1989; 257: H1315-H1320.
39. Brigham KL. Mechanisms of endothelial injury. In: Ryan US, ed. Pulmonary endothelium in health and disease. New York, Dekker, 1987; pp. 207-236.
40. Elliott SJ, Meszaros JG, Schilling WP. Effect of oxidant stress on calcium signaling in vascular endothelial cells. Free Rad Biol Med 1992; 13: 635-650.
41. Brigham KL, Mayrick B. Interactions of granulocytes with the lungs. Circ Res 1984; 54: 623-635.
42. Brigham KL, Meyrick B, Berry LC, Repine JE. Antioxidants protect cultured bovine lung endothelial cells from injury by endotoxin. J Appl Physiol 1987; 63: 840-850.
43. Kawada T, Kambara K, Arakawa M, et al. Pretreatment with catalase or dimethyl sulfoxide protects alloxan-induced acute lung edema in dogs. J Appl Physiol 1992; 73: 1326-1333.
44. Chen X, Gillis CN. Effect of free radicals on pulmonary vascular response to acetylcholine. J Appl Physiol 1991; 71: 821-825.
45. Rimar S, Gillis CN. The effect of oxygen radicals on pulmonary endothelial function. In: Weir EK, Archer SL, Reeves JT, eds. Nitric oxide and radicals in the pulmonary vasculature. Armonk, Futura Publishing Company, 1996; pp. 87-104.
46. 2 in pulmonary endothelium. Am J Physiol 1989; 257: L430-L437.
47. McConkey DJ, Orrenius S. The role of calcium in free radical-induced cell damage. In: Rice-Evans C, Halliwell B, eds. Free radicals: methodology and concept. London, Richelieu Press, 1988; pp. 419-428.
48. Katusic ZS, Vanhoutte PM. Superoxide anion is an endothelium-derived contracting factor. Am J Physiol 1989; 257: H33-H37.
49. Cherry PD, Omar HA, Farrell KA, Stuart JS, Wolin MS. Superoxide anion inhibits cGMP-associated bovine pulmonary arterial relaxation. Am J Physiol 1990; 259: H1056-H1062.
50. Katusic ZS. Superoxide anion and endothelial regulation of arterial tone. Free Radic Biol Med 1996; 20: 443-448.
51. Wu M, Pritchard KA Jr, Kaminski PM, Fayngersh RP, Hintze TH, Wolin MS. Involvement of nitric oxide and nitrosothiols in relaxation of pulmonary arteries to peroxinitrite. Am J Physiol 1994; 266: H2108-2113.
52. Villa LM, Salas E, Darley-Usmar VM, Radomski MW, Moncada S. Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart. Proc Natl Acad Sci USA 1994; 91: 12383-12387.
53. Chabot F, Mitchell JA, Quinlan GJ, Evans TW. Characterisation of the vasodilator properties of peroxynitrite on rat pulmonary artery: role of poly (adenosine 5′-diphosphoribose) synthase. Brit J Pharmacol 1997; 121: 485-490.
54. Burke TM, Wolin MS. Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation. Am J Physiol 1987; 252: H721-H732.
55. Packer CS, Rhoades RA. Impaired pulmonary vascular smooth muscle function in lung injury. In: Johnson A, Ferro TJ, eds. Lung vascular injury. New York, Dekker, 1992; pp. 227-262.
56. Rhoades RA, Jin N, Patterson CE, Roepke DA, Packer CS. Oxidant stress alters signaling mechanisms in pulmonary arterial smooth muscle. In: Weir EK, Archer SL, Reeves JT, eds. Nitric oxide and radicals in the pulmonary vasculature. Armonk, Futura Publishing Company, 1996; pp. 265-287.
57. Yamaguchi K, Asano K, Mori M, et al. Constriction and dilatation of pulmonary arterial ring by hydrogen peroxide. Importance of prostanoids. In: Hogan MC, et al, eds. Oxygen transport to tissue XV1. New York, Plenum Press, 1994; pp. 457-463.
58. Harlan JM, Wright DG. Neutrophil-mediated endothelial injury in vitro: mechanisms of cell detachment. J Clin Invest 1981; 68: 1394-1403.
59. Shasby DM, Vanbenthuysen KM, Tate RM, Shasby S, McMurtry I, Repine JE. Granulocytes mediate acute edematous lung injury in rabbits and in isolated rabbit lungs perfused with phorbol myristate acetate: role of oxygen radicals. Am Rev Respir Dis 1982; 125: 443-447.
60. Flick MR, Perel A, Staub NC. Leukocytes are required for increased lung microvascular permeability after microembolization in sheep. Circ Res 1981; 48: 344-351.
61. Haslett C, Guthrie LA, Kopaniak MM, Johnston RB, Henson PM. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 1985; 119: 101-110.
62. Kharazmi A, Nielsen H, Bendzen K. Recombinant interleukin-1 alpha and beta prime human monocyte superoxide production but have no effect on chemotaxis and oxidative burst response of neutrophils. Immunobiology 1988; 177: 32-39.
63. Berkow RL, Wang D, Larrick JW, Dodson RW, Howard TH. Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor. J Immunol 1987; 139: 3783-3791.
64. Minamiya Y, Abo S, Kitamura M, et al. Endotoxin-induced hydrogen peroxide production in intact pulmonary circulation of rat. Am J Respir Crit Care Med 1995; 152: 348-354.
65. Whorthen GS, Haslett C, Rees AJ, Gumbay RS, Henson JE, Henson PM. Neutrophil-mediated pulmonary vascular injury: synergistic effects of trace amounts of lipopolysaccharide and neutrophil stimuli on vascular permeability and neutrophil sequestration in the lung. Am Rev Respir Dis 1987; 136: 19-28.
66. Pabst MJ, Hedegaard HB, Johnston RB. Cultured human monocytes require exposure to bacterial products to maintain an optimal oxygen radical response. J Immunol 1982; 128: 123-128.
67. Newton RC. Human monocyte production of interleukin-1: parameters of the induction of interleukin-1 secretion by lipopolysaccharides. J Leukoc Biol 1986; 39: 234-299.
68. Warren JS, Ward PA. Immunoglobulin-and complement-mediated immune injury. In: Crystal RG, West JB, Barnes PJ, Weibel ER, eds. The Lung. Philadelphia, Lippincott-Raven, 1997; pp. 2411-2419.
69. Rodell TC, Cheronis JC, Ohnemus CL, Piermattei DJ, Repine JE. Xanthine oxidase mediates elastase induced injury to isolated lungs and endothelium. J Appl Physiol 1987; 63: 2159-2163.
70. Terada LS, Donnish JJ, Shanley PF, Leff JA, Anderson BO, Repine JE. Circulating xanthine oxidase mediates lung neutrophil sequestration after intestinal ischemia-reperfusion. Am J Physiol 1992; 263: L394-L401.
71. Read MA, Meyrick BO. Effects of endotoxin on lung endothelium. In: Brigham KL, ed. Endotoxin and the lung. New York, Dekker, 1994; pp. 83-110.
72. Heflin AC, Brigham KL. Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia. J Clin Invest 1981; 68; 1253-1260.
73. Bernard GR, Lucht WD, Niedermeyer ME, Snapper JR, Ogletree ML, Brigham KL. Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function. J Clin Invest 1984; 73: 1772-1784.
74. Demling MD, Lalonde C, Seekamp A, Fiore N. Endotoxin causes hydrogen peroxide-induced lung lipid peroxidation and prostanoid production. Arch Surg 1988; 123: 1337-1341.
75. Frank L, Summerville J, Massaro D. Protection from oxygen toxicity with endotoxin: role of the endogenous antioxidant enzymes of the lung. J Clin Invest 1980; 65: 1104-1110.
76. Shiki Y, Meyrick BO, Brigham KL, Burr IM. Endotoxin increases superoxide dismutase in cultured bovine pulmonary endothelial cells. Am J Physiol 1987; 252: C436-C440.
77. Visner GA, Block ER, Burr IM, Nick HC. Regulation of manganese superoxide dismutase in porcine pulmonary artery endothelial cells. Am J Physiol 1991; 260: L444-L449.
78. White CW, Ghezzi P, Dinarello CA, Caldwell SA, McMurtry IJ, Repine JE. Recombinant tumor necrosis factor/cachectin and interleukin-1 pretreatment decreases lung oxidized glutathione accumulation, lung injury and mortality in rats exposed to hyperoxia. J Clin Invest 1987; 79: 1868-1873.
79. Kelly FJ. Free radical disorders of preterm infants. In: Cheeseman KH, Slater TF, eds. Free Radicals in Medicine. British Medical Bulletin, Vol. 49. London, Churchill Livingstone, 1993; pp. 668-678.
80. Adkins WK, Taylor AE. Role of xanthine oxidase and neutrophils in ischemia-reperfusion injury in rabbit lung. J Appl Physiol 1990; 69: 2012-2018.
81. Horgan MJ, Lum H, Malik AB. Pulmonary edema after pulmonary artery occlusion and reperfusion. Am Rev Respir Dis 1989; 140: 1421-1428.
82. Kennedy TP, Rao NV, Hopkins C, Pennington L, Tolley E, Hoidal JR. Role of reactive oxygen species in reperfusion injury of the rabbit lung. J Clin Invest 1989; 83: 1326-1335.
83. Bishop MJ, Chi EY, Su M, Cheney FW. Dimethylthiourea does not ameliorate reperfusion lung injury in dogs or rabbits. J Appl Physiol 1988; 65: 2051-2056.
84. Lum H, Barr DA, Shaffer JR, Gordon RJ, Ezrin AM, Malik AB. Reoxygenation of endothelial cells increases permeability by oxidant-dependent mechanisms. Circ Res 1992; 70: 991-998.
85. Zweier JL, Kuppusamy P, Lutty GA. Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in post-ischemic tissues. Proc Natl Acad Sci USA 1988; 85: 4046-4050.
86. Bysani GK, Kennedy TP, Ky N, Rao NV, Blaze CA, Hoidal JR. Role of cytochrome P-450 in reperfusion injury of the rabbit lung. J Clin Invest 1990; 86: 1434-1441.
87. Jackson RM, Veal CF. Effects of hypoxia and reoxygenation on lung glutathione system. Am J Physiol 1990; 259: H518-H524.
88. Ischiropoulos H, Al-Mehdi AB, Fisher AB. Reactive species in ischemic rat lung injury: contribution of peroxynitrite. Am J Physiol 1995; 269: L158-L164.
89. Moore TM, Khimenko PL, Wilson PS, Taylor AE. Role of nitric oxide in lung ischemia and reperfusion injury. Am J Physiol 1996; 271: H1970-H1977.
90. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159-163.
91. Takahashi S, Suzuki S, Takeuchi K, et al. Role of endothelium for tissue damage by active oxygen radicals in heart-lung transplantation. Transplant Proceed 1993; 25: 1676-1677.
92. Shasby DM, Lind SE, Shasby SS, Goldsmith JC, Hunninghake GW. Reversible oxidant-induced increases in albumin transfer across cultured endothelium: alterations in cell shape and calcium homeostasis. Blood 1985; 65: 605-614.
93. Heffner JE, Fracica P. Ischemia-reperfusion edema of the lung. In: Weir EK, Archer SL, Reeves JT, eds. Nitric oxide and radicals in the pulmonary vasculature. Armonk, Futura Publishing Company, 1996; pp. 105-133.
94. Phan SH, Gannon DE, Varani J, Ryan US, Ward PE. Xanthine oxidase activity in rat pulmonary artery endothelial cells and its alteration by activated neutrophils. Am J Pathol 1989; 134: 1201-1211.
95. Hachida M, Morton DL. The protection of ischemic lung with verapamil and hydralazine. J Thorac Cardiovasc Surg 1988; 95: 178-183.
96. Cofleski JT, Evans JN. Pharmacologic properties of isolated proximal pulmonary arteries after seven-day exposure to in vivo hyperoxia. Am Rev Respir Dis 1988; 138: 945-951.
97. Crapo JD. Morphologic changes in pulmonary oxygen toxicity. Ann Rev Physiol 1986; 48: 721-731.
98. Freeman BA, Crapo JD. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J Biol Chem 1981; 256: 10986-10992.
99. Sanders SP, Zweier JL, Kuppusamy P, et al. Hyperoxic sheep pulmonary microvascular endothelial cells generate free radicals via mitochondrial electron transport. J Clin Invest 1993; 91: 46-52.
100. Suttorp N, Simon LM. Lung cell oxidant injury: enhancement of polymorphonuclear leukocyte-mediated cytotoxicity in lung cells exposed to sustained in vitro hyperoxia. J Clin Invest 1982; 70: 342-350.
101. Deneke SM, Lynch BA, Fanburg BL. Transient depletion of lung glutathione by diethylmaleate enhances oxygen toxicity. J Appl Physiol 1985; 58: 571-574.
102. Lewis-Molock Y, Suzuki K, Taniguchi N, Nguyen DH, Mason RJ, White CW. Lung manganese superoxide dismutase increases during cytokine-mediated protection against pulmonary oxygen toxicity in rats. Am J Respir Cell Mol Biol 1994; 10: 133-141.
103. Clerch LB, Massaro D. Tolerance of rats to hyperoxia: lung antioxidant enzyme gene expression. J Clin Invest 1993; 91: 499-508.
104. Jornot L, Junod AF. Response of human endothelial cell antioxidant enzymes to hyperoxia. Am J Respir Cell Mol Biol 1992; 6: 107-115.
105. Lindau-Shepard B, Shaffer JB, Del Vecchio PJ. Overexpression of manganous superoxide dismutase (MnSOD) in pulmonary endothelial cells confers resistance to hyperoxia. J Cell Physiol 1994; 161: 237-242.
106. Vijeyaratnam GS, Corrin B. Experimental paraquat poisoning: a histological and electron-optical study of the changes in the lung. J Pathol 1971; 103: 123-129.
107. Smith LL. The response of the lung to foreign compounds that produce free radicals. Ann Rev Physiol 1986; 48: 681-692.
108. Fisher HK, Clements JA, Wright RR. Enhancement of oxygen toxicity by the herbicide paraquat. Am Rev Respir Dis 1973; 107: 246-252.
109. Camus Ph. Pathophysiology of drug-induced lung disease. In: Akoun GM, White JP, eds. Treatment-induced respiratory disorders. Amsterdam, Elsevier, 1989; pp. 24-46.
110. Gutteridge JMC, Quinlan GJ. Reactive oxygen species, antioxidant protection and lung injury. In: ARDS Acute respiratory distress syndrome in adults. Haslett C, Evans TW, eds. London, Chapman & Hall Medical, 1996; pp. 167-195.
111. Baldwin SR, Simon RH, Grum CM, Ketai LH, Boxer LA, Devall LJ. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet 1986; 1: 11-14.
112. Sznajder JI, Fraiman A, Hall JB, et al. Increased hydrogen peroxide in the expired breath of patients with acute hypoxemic respiratory failure. Chest 1989; 96: 606-612.
113. Cochrane CG, Spragg RG, Revak SD, Cohen AB, McGuire WW. The presence of neutrophil elastase and evidence of oxidation activity in bronchoalveolar ravage fluid of patients with adult respiratory syndrome. Am Rev Respir Dis 1983; 127: 25-27.
114. Bernard GR, Swindell BB, Meredith MJ, et al. Glutathione (GSH) repletion by N-acetylapleine (NAC) in patients with the adult respiratory distress syndrome (ARDS). Am Rev Respir Dis 1989; 139: A221.
115. Pacht ER, Timoman AP, Lykens MG, et al. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 1991; 100: 1397-1403.
116. Quinlan GJ, Evans TW, Gutteridge JMC. Linoleic acid and protein thiol changes syggestive of oxidative damage in the plasma of patients with adult respiratory distress syndrome. Free Rad Res 1994; 20: 299-306.
117. Gutteridge JMC, Quinlan GJ, Mumby S, et al. Primary plasma antioxidants in adult respiratory distress syndrome patients: changes in iron-oxidising, iron-binding and free radical scavenging proteins. J Lab Clin Invest 1994; 124: 263-273.
118. Gutteridge JMC, Mumby S, Quinlan GJ, Chung KF, Evans TW. Pro-oxidant iron is present in human pulmonary epithelial lining fluid: implications for oxidative stress in the lung. Biochem Biophys Res Commun 1996; 220: 1024-1027.
119. Richard C, Lemonnier F, Thibault M, Auzepy P. Vitamine E deficiency and lipoperoxidation during adult respiratory distress syndrome. Crit Care Med 1990; 18: 4-9.
120. Quinlan GJ, Evans TW, Gutteridge JMC. 4-Hydroxy-2-nonenal levels increase in the plasma of patients with adult respiratory distress syndrome as linoleic acid appears to fall. Free Rad Res 1994; 21: 95-106.
121. Quinlan GJ, Evans TW, Gutteridge JMC. Oxidative damage to plasma proteins in adult respiratory distress syndrome. Free Rad Res 1994; 20: 289-298.
122. Grum CM, Ragsdale RA, Ketai LH, Simon RH. Plasma xanthine oxidase activity in patients with ARDS. J Crit Care 1987; 2: 22-26.
123. Quinlan GJ, Lamb NJ, Tilley R, Evans IW, Gutteridge JMC. Plasma hypoxanthine levels in ARDS: implications for oxidative stress; morbidity and mortality. Am J Respir Crit Care Med 1997; 155: 479-484.
124. Lamb NJ, Gutteridge JMC, Evans TW, Baker CS, Quinlan GJ. Increased levels of oxidative protein damage are present in BAL fluid from patients with ARDS. Submitted.
125. Cross CE, Forte T, Stocker R, et al. Oxidative stress and abnormal cholesterol metabolism in patients with adult respiratory distress syndrome. J Lab Clin Med 1990; 115: 391-404.
126. Bertrand Y, Pincemail J, Hanique G, et al. Differences in tocopherol-lipid ratios in ARDS and non-ARDS patients. Int Care Med 1989; 15: 87-93.
127. Gutteridge JMC, Quinlan GJ, Evans TW. Transient iron-overload with bleomycin-detectable iron in the plasma of patients with adult-respiratory distress syndrome. Thorax 1994; 49: 707-710.
128. Fowler M, Hamman RF, Good JT, et al. Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med 1983; 98: 593-597.
129. Asada S, Yamaguchi M. Fine structural change in the lung following cardiopulmonary bypass. Chest 1971; 59: 478-483.
130. Macnaughton PD, Braude S, Hunter DN, Denison DM, Evans TW. Changes in lung function and pulmonary capillary permeability after cardiopulmonary bypass. Crit Care Med 1992; 20: 1289-1294.
131. Braude S, Nolop KB, Fleming JS, Krausz T, Taylor KM, Royston D. Increased pulmonary transvascular protein flux after canine cardiopulmonary bypass. Am Rev Respir Dis 1986; 134: 867-872.
132. Cavarocchi NC, England MD, Schaff HV, et al. Oxygen free radical generation during cardiopulmonary bypass: correlation with complement activator. Circulation 1986; 74: III130-III136.
133. Prasad K, Kalra J, Bharadwaj B, Chaudhary AK. Increased oxygen free radical activity in patients on cardiopulmonary bypass undergoing aortocoronary bypass surgery. Am Heart J 1992; 123: 37-45.
134. Morita K, Ihnken K, Buckberg GD, Sherman MP, Ignarro LJ. Pulmonary vasoconstriction due to impaired nitric oxide production after cardiopulmonary bypass. Ann Thorac Surg 1996; 61: 1775-1780.
135. Gutteridge JMC. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett 1986; 201: 291-295.
136. Pepper JR, Mumby S, Gutteridge JMC. Blood cardioplegia increases plasma iron overload and thiol levels during cardiopulmonary bypass. Ann Thorac Surg 1995; 60: 1735-1740.
137. Quinlan GJ, Westerman ST, Mumby S, Pepper JR, Gutteridge JMC. Plasma hypoxanthine levels during crystalloid and blood cardioplegias: warm blood cardioplegia increases hypoxanthine levels with a greater risk of oxidative stress. J Cardiovasc Surg 1998; (in press).
138. Kirk AJB, Colquhoun IW, Dark JH. Lung preservation: a review of current practice and future directions. Ann Thorac Surg 1993; 56: 990-1000.
139. Stuart RS, Baumgartner WA, Borkon AM, et al. Five-hour hypothermie lung preservation with oxygen free-radical scavengers. Transplant Proceed 1985; 17: 1454-1456.
140. Cale ARJ, Ricagna F, Wiklund L, McGregor CGA, Miller VM. Mononuclear cells from dogs with acute lung allograft rejection cause contraction of pulmonary arteries. Circulation 1994; 90: 952-958.
141. Martin TR, Sandblom RL, Johnson RJ. Aduit respiratory distress syndrome following thrombolytic therapy for pulmonary embolism. Chest 1983; 83: 151-153.
142. Tomashefski JF, Davies P, Boggis C, Greene R, Zapol WM, Reid LM. The pulmonary vascular lesions of the adult respiratory distress syndrome. Am J Pathol 1983; 112: 112-126.
143. Suzuki Y, Tanigaki T, Heimer D, et al. Polyethylene glycolconjugated superoxide dismutase attenuates septic lung injury in guinea pigs. Am Rev Respir Dis 1992; 145: 388-393.
144. Amari T, Kubo K, Kobayashi T, Sekiguchi M. Effects of recombinant human superoxide dismutase on tumor necrosis factor-induced lung injury in awake sheep. J Appl Physiol 1993; 74: 2641-2648.
145. Ferro TJ, Hocking DC, Johnson A. Tumor necrosis factor-α alters pulmonary vasoreactivity via neutrophil-derived oxidants. Am J Physiol 1993; 265: L462-L471.
146. Lui SF, Dewar A, Crawley DE, Barnes PJ, Evans TW. Effects of tumour necrosis factor on hypoxic pulmonary vasoconstriction and endothelium-dependent relaxation in the blood-perfused rat lung. J Appl Physiol 1992; 72: 1044-1048.
147. Flick MR, Milligan SA, Hoeffel JM, Goldstein IM. Catalase prevents increased lung permeability during air emboli in unanesthetized sheep. J Appl Physiol 1988; 64: 929-935.
148. Boissinot M, Kuhn LA, Lee P, et al. Rational design and expression of a heparin-targeted human superoxide dismutase. Biochem Biophys Res Comm 1993; 190: 250-256.
149. Turrens JF, Crapo JD, Freeman BA. Protection against oxygen-toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J Clin Invest 1984; 73: 87-95.
150. McCord JM. Superoxide radical: controversies, contradictions, and paradoxes. Proc Soc Exp Biol Med 1995; 209: 112-117.
151. Bernard GR. N-acetylcysteine in experimental and clinical acute lung injury. Am J Med 1991; 91: 54S-59S.
152. Suttorp N, Toepper W, Roka L. Antioxidant defense mechanisms of endothelial cells: gluthatione redox cycle versus catalase. Am J Physiol 1986; 251: C671-C680.
153. Dillard CJ, Litov RE, Savin WM, Dumelin E, Tappel AL. Effects of exercise, vitamin E and ozone on pulmonary function and lipid peroxidation. J Appl Physiol 1978; 45: 927-932.
154. Yoshikawa T, Furukawa Y, Murakami M, Vatanabe K, Kondo M. Effect of vitamin E on endotoxin-induced disseminated intravascular coagulation in rats. Thromb Haemost 1982; 48: 235-237.
155. Jepsen S, Herlevsen P, Knudsen P, Bud MI, Klausen NO. Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study. Crit Care Med 1992; 20: 918-923.
156. Toth KM, Harlan JM, Berger EM, Parker NB, Repine JE. Dimethylthiourea prevents hydrogen peroxide mediated damage to bovine pulmonary artery endothelial cells and disappears in the process. Free Rad Bio Med 1989; 6: 457-466.
157. Olson NC, Anderson DL, Grizle MK. Dimethylthiourea attenuates endotoxin-induced acute respiratory failure in pigs. J Appl Physiol 1987; 63: 2426-2432.
158. Rubanyi GM, Ho EH, Cantor EH, Lumma WC, Parker Botelho LH. Cytoprotective function of nitric oxide: inactivation of superoxide radicals produced by human leukocytes. Biochem Biophys Res Commun 1991; 181: 1392-1397.
159. Fukahori M, Ichimori K, Ishida H, Nakagawa H, Okino H. Nitric oxide reversably suppresses xanthine oxidase activity. Free Rad Res 1994; 21: 203-212.
160. Singh S, Evans TW. Nitric oxide, the biological mediator of the decade: fact or fiction? Eur Respir J 1997; 10: 699-707.
161. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328: 399-405.